135 related articles for article (PubMed ID: 12221545)
1. [Cytomegalovirus retinitis after highly active antiretroviral therapy: a case report].
Andonegui Navarro J; Aldamiz-Etxebarría M
Arch Soc Esp Oftalmol; 2002 Sep; 77(9):515-7. PubMed ID: 12221545
[TBL] [Abstract][Full Text] [Related]
2. Multiple relapses of human cytomegalovirus retinitis during HAART in an AIDS patient with reconstitution of CD4+ T cell count in the absence of HCMV-specific CD4+ T cell response.
Lilleri D; Piccinini G; Baldanti F; Seminari E; Galloni D; Gerna G
J Clin Virol; 2003 Jan; 26(1):95-100. PubMed ID: 12589839
[TBL] [Abstract][Full Text] [Related]
3. Results of the ALBI trial: a randomized comparison of stavudine/didanosine, zidovudine/lamivudine and alternating treatment in antiretroviral-naive patients.
Molina JM; Chêuc G; Ferchal F; Journot V; Pellegrin I; Sombardier MN; Rancinan C; Cotte L; Madelaine I; Debord T; Decazes JM;
Antivir Ther; 1999; 4 Suppl 3():71-4. PubMed ID: 16021874
[TBL] [Abstract][Full Text] [Related]
4. Antiretroviral triple therapy decreases HIV viral load but does not alter hepatitis C virus (HCV) serum levels in HIV-HCV-co-infected haemophiliacs.
Rockstroh JK; Theisen A; Kaiser R; Sauerbruch T; Spengler U
AIDS; 1998 May; 12(7):829-30. PubMed ID: 9619824
[No Abstract] [Full Text] [Related]
5. Nonprogressive CMV retinitis in AIDS patients with protease inhibitors therapy for AIDS.
Ortega-Larrocea G; Feregrino-Goyos M
Ocul Immunol Inflamm; 1997 Dec; 5(4):279-82. PubMed ID: 9455745
[TBL] [Abstract][Full Text] [Related]
6. Characteristics of untreated AIDS-related cytomegalovirus retinitis. II. Findings in the era of highly active antiretroviral therapy (1997 to 2000).
Holland GN; Vaudaux JD; Shiramizu KM; Yu F; Goldenberg DT; Gupta A; Carlson M; Read RW; Novack RD; Kuppermann BD;
Am J Ophthalmol; 2008 Jan; 145(1):12-22. PubMed ID: 18154751
[TBL] [Abstract][Full Text] [Related]
7. Regression of cytomegalovirus retinitis associated with protease-inhibitor treatment in patients with AIDS.
Tanguilig GG; Rutzen AR; Ortega-Larrocea G
Am J Ophthalmol; 1998 Apr; 125(4):567-8. PubMed ID: 9559752
[No Abstract] [Full Text] [Related]
8. Characterization of reactivation of cytomegalovirus retinitis in patients healed after treatment with highly active antiretroviral therapy.
Song MK; Karavellas MP; MacDonald JC; Plummer DJ; Freeman WR
Retina; 2000; 20(2):151-5. PubMed ID: 10783947
[TBL] [Abstract][Full Text] [Related]
9. Immune reconstitution syndromes in human immuno-deficiency virus infection following effective antiretroviral therapy.
Behrens GM; Meyer D; Stoll M; Schmidt RE
Immunobiology; 2000 Aug; 202(2):186-93. PubMed ID: 10993293
[TBL] [Abstract][Full Text] [Related]
10. The 48-week efficacy of once-daily saquinavir/ritonavir in patients with undetectable viral load after 3 years of antiretroviral therapy.
Cardiello P; Srasuebkul P; Hassink E; Mahanontharit A; Samor T; Ruxrungtham K; Lange J; Cooper D; Phanuphak P
HIV Med; 2005 Mar; 6(2):122-8. PubMed ID: 15807718
[TBL] [Abstract][Full Text] [Related]
11. [Antiretroviral treatment in human immunodeficiency virus infection].
Blum L; Bachmeyer C
Ann Dermatol Venereol; 1997; 124(9):641-54. PubMed ID: 9739932
[No Abstract] [Full Text] [Related]
12. Antiretroviral treatment. HIV infection in adults: better-defined first-line treatment.
Prescrire Int; 2004 Aug; 13(72):144-50. PubMed ID: 15532140
[TBL] [Abstract][Full Text] [Related]
13. Effect of potent antiretroviral therapy on recurrent cytomegalovirus retinitis treated with the ganciclovir implant.
Davis JL; Tabandeh H; Feuer WJ; Kumbhat S; Roth DB; Chaudhry NA
Am J Ophthalmol; 1999 Mar; 127(3):283-7. PubMed ID: 10088737
[TBL] [Abstract][Full Text] [Related]
14. [Cystoid macular edema and cytomegalovirus retinitis in AIDS patients treated with antiretroviral triple therapy].
Badelon I; Gohier P; Chaine G
J Fr Ophtalmol; 1999 Dec; 22(10):1034-41. PubMed ID: 10617840
[TBL] [Abstract][Full Text] [Related]
15. Subretinal hemorrhage in cytomegalovirus retinitis.
Freidlin J; Sharma MC; Goldstein DA
Ophthalmic Surg Lasers Imaging; 2005; 36(1):73-5. PubMed ID: 15688975
[TBL] [Abstract][Full Text] [Related]
16. [Observational study on the efficacy of the application of two classical regimens of triple antiretroviral therapy].
Eiros Bouza JM; Ortega Lafont M; Ortiz de Lejarazu R; Bachiller Luque P; de Luis Román DA
An Med Interna; 2003 May; 20(5):239-42. PubMed ID: 12831297
[TBL] [Abstract][Full Text] [Related]
17. Protease inhibitors linked to drop in CMV retinitis.
AIDS Alert; 1997 Aug; 12(8):92-4. PubMed ID: 11364475
[TBL] [Abstract][Full Text] [Related]
18. Cytomegalovirus retinitis in advanced HIV-infected patients treated with protease inhibitors: incidence and outcome over 2 years.
Labetoulle M; Goujard C; Frau E; Rogier H; Niessen F; Furlan V; Lantz O; Lecointe D; Delfraissy JF; Offret H
J Acquir Immune Defic Syndr; 1999 Nov; 22(3):228-34. PubMed ID: 10770342
[TBL] [Abstract][Full Text] [Related]
19. Stavudine plus a non-thymidine nucleoside reverse transcriptase inhibitor as a backbone for highly active antiretroviral therapy.
Clumeck N
Antivir Ther; 1998; 3 Suppl 4():39-43. PubMed ID: 10723508
[TBL] [Abstract][Full Text] [Related]
20. Safety and efficacy of ritonavir and saquinavir in combination with zidovudine and lamivudine.
Michelet C; Bellissant E; Ruffault A; Arvieux C; Delfraissy JF; Raffi F; Bazin C; Renard I; Sébille V; Chauvin JP; Dohin E; Cartier F
Clin Pharmacol Ther; 1999 Jun; 65(6):661-71. PubMed ID: 10391672
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
